Abstract. Evidence has shown that the lack of tau produces subtle changes in neuronal structure and modest impairment in complex behaviors, suggesting compensatory mechanisms carried out by other neuronal microtubule-associated proteins. Here we show major abnormalities in sleep-wake cycle of tau-deficient animals including increased wakefulness duration and decreased non-rapid eye movement (NREM) sleep time, a higher number of state transitions between NREM and wake, and shortened sleep bouts. Altered sleep structure in tau −/− mice was accompanied by a significant decline in delta power together with an enhanced spectral density of sleep spindles during NREM sleep. No significant differences were observed in rapid eye movement (REM) sleep between the two mouse strains. Taken together, these results suggest that tau indirectly participates in the regulation of the sleep-wake cycle modulating not only the control and maintenance of global brain states but also the cerebral oscillatory patterns underlying sleep-wake states.
INTRODUCTION
Morphological stability of neuronal cytoskeleton occurs during early stages of development and plays a critical role in maintenance and formation of axons and dendrites. Different lines of evidence suggest that properties of cytoskeleton stability reside in neuronal microtubules [1] , which in turn are regulated by diverse neuronal microtubule-associated proteins (MAPs), like tau, MAP2, and MAP1B [2] . Tau and MAP1B have demonstrated to assist axonal elongation and neuronal migration in a synergistic fashion [3, 4] . Apart from some mild behavioral deficits reported in tau-deficient mice [5] , likely induced by subtle decrement of microtubules in small-caliber axons [6] , the lack of neuronal tau does not produce dramatic alterations in complex behavior suggesting developmental compensatory mechanisms carried out by other neuronal MAPs [7] .
Tau protein adds stability and plastic properties to the neuronal cytoskeleton facilitating the formation of synaptic networks underlying fundamental neurobiological functions. Sleep and resting represent global states whose control mechanisms are manifested at every level of biological organization, from genes to neural circuits and cerebral systems [8] . The sleepwake cycle represents one of the best examples of self-organized operations within neuronal circuits and brain systems, requiring an exquisite synaptic coordination at multiple levels of cerebral organization. Mammal sleep is in turn regulated by circadian and homeostatic processes contributing to sleep timing and sleep structure [9] . Both processes require the coordinated interaction between suprachiasmatic nucleus and diencephalic structures, basal forebrain, and the brainstem [10] . The emergence of this complex circuitry requires both stable and plastic properties of the neuronal cytoskeleton which is assisted by tau during the early postnatal period [11] . Microtubules have also demonstrated an influence on circadian activity patterns by modulating the sensitivity states of different melatonine receptors [12, 13] .
Using chronically implanted electrodes we recorded local field potentials (LFP) in freely-moving taudeficient mice during the sleep-wake cycle. We found an impaired sleep-wake organization accompanied by significant changes in sleep electrophysiology in tau knockout mice (tau −/− ), suggesting an unexpected participation of tau protein in sleep regulation and neural oscillatory mechanisms underlying global sleep states.
MATERIALS AND METHODS

Animals
Tau
−/− mice were generated as previously described [3] . Heterozygous tau +/− mice (from C57 BL/6 × 129VJ background) were backcrossed into C57 BL/6J (Charles River Laboratories International, Inc.) for several generations to obtain a strain on a homogenous genetic C57 BL/6J background. Finally, the resulting tau +/− animals were crossed to generate homozygous tau −/− mice and their control littermates (wt tau +/+ ) (Fig. 1A) . Experiments were performed in accordance with the guidelines of the European Union Council (86/609/UE) and the Spanish regulations (BOE 67/8509-12; BOE 1201/2005) on the use of laboratory animals, and approved by the local Animal Care and Ethics Committee.
Animals were bred at the Centro de Biología Molecular "Severo Ochoa" (Madrid, Spain) and maintained following the institutional guidelines. Four to five mice were housed per cage with food and water available ad libitum, in a temperature controlled environment on a 12/12 h light-dark cycle. For electrophysiological recordings, mice were individually housed in the Ani- mal Supply and Care Service of the University of Cadiz (Cadiz, Spain). Following the mandatory quarantine period, wild type and tau −/− mice were subjected to electrode implantation surgery.
Animal behavior
Waking behavioral states were manually scored (10-s epochs) according to the following criteria: 1) active exploration (AWK): the animal was engaged in exploratory behavior (locomotion, whisking, and sniffing), showing low-amplitude cortical LPFs and high theta (5-9 Hz) and gamma (30-40 Hz) power density; 2) Quiet waking (QWK): the animal was immobile (standing or sitting quietly) or engaged in "automatic" stereotype behaviors (eating, drinking, and grooming), with low-amplitude cortical LFPs and relatively high theta and gamma activity but less than during AWK.
Surgery
Mice (n = 6 for each genotype) were anesthetized with ketamine/xylidine-dihydrothiazine (35:1 mg / kg, i.m.). One hole overlying the hippocampus (approximately 1 mm in diameter) was drilled to permit targeting of the CA1 subfield under stereotaxic guidance. Electrode wire for hippocampal LFP recordings was made of stainless steel (60 µm diameter; reference n • 796000; A-M systems, Carlsborg, WA) and implanted over the right cerebral hemisphere (1.9 mm posterior from bregma, 2 mm lateral from midline, and 1.5 mm from the dura). Once the electrode was implanted at the hippocampus, the hole was covered with a mixture of paraffin oil and wax. Additionally, one stainless steel electrode (50 µm diameter; reference n • 790700; A-M systems, Carlsborg, WA) was implanted in the primary somatosensory cortex-forelimb area (0 mm to bregma and 2 mm lateral to midline). The common reference electrode was located above the cerebellum (1 mm posterior to lambda on midline). Two insulated stainless steel, Teflon-coated wires bilaterally placed into both trapezius muscles served as electromyography (EMG) electrodes. All electrodes were attached to a microconnector and fixed to the skull with dental cement. Mice were allowed to recover for two weeks from surgery before experimental sessions, and habituated to the experimental settings during 24 h prior to the recording session.
Electrophysiological data acquisition
LFPs and EMG were continuously recorded for 24 h in the animal's home cage. Electrophysiological signals were amplified by a factor of 20000, conditioned by an analog high-pass filter (−3 dB at 0.016 Hz) and sampled at 200 Hz by using PowerLab/8SP A/D interface (AD Instruments, Castle Hill, Australia). Raw signals were stored in a computer for off-line analysis.
Scoring of sleep-wake states
LFP recordings were manually scored (10-s epochs) in different behavioral states according to the following criteria [14, 15] : 1) active (AWK) and quiet (QWK) waking (for a description, see the animal behavior section); 2) In non-rapid eye movement (NREM), the animal was lying immobile with eyes closed and slow regular respiratory movements, beginning with sleep spindles (10-14 Hz) superimposed to delta waves (1-4 Hz) (NREM1). As slow-wave sleep deepens, delta oscillations become predominant, although isolated spindles can still be observed (NREM2). 3) In REM sleep, the animal was immobile and atonic except for intermittent whisker and ear twitches, with low cortical LFP amplitude and high theta and gamma power. Scoring of sleep-wake states was performed blind to genotype.
After scoring each 10-s epoch, the following parameters were obtained for each mouse and cerebral state (total wake, AWK, QWK, total NREM, NREM1, NREM2, and REM): state duration, number of episodes, mean duration of episodes, and number of episodes per hour. The number of transitions between global states was also obtained to determine whether the lack of tau selectively affected the prevalence of specific transitions. Similarly, the number of wake and sleep bouts of different duration (ranged from 10 to 2560 s) were grouped to explore the influence of tau at maintaining the continuity of wakefulness and sleep. Each of these parameters was separately obtained in different periods (12-h light/12-h dark/24-h) for each animal.
Quantitative analysis of LFP signals
LFP epochs containing artifacts were marked and omitted from further quantitative analysis. Spectral analysis was performed on cumulated artifact-free LFP 10-s epochs of total wake, AWK, QWK, total NREM, NREM1, NREM2, and REM by applying a fast Fourier transform (Welch's modified periodogram method), yielding power spectra between 0.5 and 40 Hz with a 0.5 Hz resolution. The mean LFP spectrum was obtained by averaging 10-s epochs to obtain a spectral profile for each behavioral state and genotype. To minimize non-specific differences in absolute power between individuals, LFP power densities in each frequency bin were expressed as a percentage of mean total LFP power for each cerebral state. All analyses were performed with Matlab v. 7.4 (The MathWorks Inc., Natick, MA).
Statistical analysis
Differences in each sleep-wake parameter between wt and tau −/− mice were separately tested by using non-paired, one-way ANOVAs (Mann-Whitney U test). Effects of tau protein on power spectra for each behavioral state were similarly assessed. In all cases, p < 0.05 was considered as the significance threshold. Statistical analyses were performed with SPSS v. 16 (SPSS Inc., Chicago, IL).
Histology
Following completion of the electrophysiological experiments, mice were deeply anesthetized with a high dose of Nembutal (100 mg/kg). Keeping the electrode in situ, animals were perfused. Brains were extracted and placed in fixative for 24-48 h, and then cut into 80-µm-thick sections using a vibratome. For verification of electrode placement, sections were mounted on gelatin-coated slides, stained with the Nissl method, dehydrated, and studied with light microscopy.
Tau immunohistochemistry
Wt and tau
−/− mice anesthetized with xylazine/ ketamine were perfused with phosphate-buffered saline (PBS) first and then, 4% (w/v) paraformaldehyde (PFA) in Sorensen's buffer. Brains were incubated with 4% PFA for 2 h and cryoprotected in 30% (w/v) sucrose solution. Brains were cut in 30-µm-thick sagittal sections on a freezing microtome (Leica) and collected in glycol solution (20 mM phosphate buffer with 30% (v/v) glycerol and 30% (v/v) etylenglycol). Sections were incubated for 1 h with 1% (w/v) bovine serum albumin (BSA), 5% (w/v) fetal bovine serum (FBS), and 0.2% (v/v) Triton X-100, and then with the monoclonal primary antibody tau-1 (Chemicon) raised against tau protein [16] and diluted (1/500). Finally, samples were incubated in avidin-biotin complex using the Elite Vectastain kit (Vector Laboratories). Chromogen reactions were performed with diaminobenzidine (DAB; Sigma) and 0.003% (v/v) H 2 O 2 for 10 min. Sections, mounted in Depex (Labclinics), were imaged using a stereomicroscope model MZ95 coupled to a digital camera (Leica).
Western blot analysis
Brains from wt and tau −/− mice were homogenized at 4
• C in a buffer containing 20 mM Hepes pH 7.4, 100 mM NaCl, 20 mM NaF, 5 mM EDTA, 1% (v/v) Triton TX-100, 30 mM Glycerophosphate, 5 M Pyrophosphate, 1 µM okadaic acid, and a cocktail of protease inhibitors (Roche). Lysates were centrifuged at 12,000 x g for 15 min at 4
• C. Supernatants in electrophoresis buffer were run on 10% SDS-PAGE gels and electrophoretically transferred to a nitrocellulose membrane (Schleicher & Schuell). After blocking of non-specific protein binding with 5% (w/v) non-fat dried milk and 0.05% (v/v) Tween 20 in PBS, the filters were incubated in the presence of the primary antibody at 4
• C overnight in blocking buffer. Primary antibodies used were: BR-133 to detect the C-terminal part of tau protein (1/1,000; a gift from Dr. C. Wischik, MRC, Cambridge, UK), PHF-1 to detect phosphorylated tau (1/1,000; a gift of Dr. P. Davies, Albert Einstein University, NY, USA), and anti-β-actin (1/1,000; SigmaAldrich). The immunoreactive bands were displayed using enhanced chemiluminescence (Amersham Biosciences) after the incubation with horseradish peroxidase (HRP)-linked secondary antibodies (Invitrogen).
Gene expression analysis
For transcriptional analysis, Affymetrix MOE 430A 2.0 GeneChip was used, which analyzes 14000 annotated mouse genes. Hippocampal tissue from tau −/− mice and control littermates (n = 3 per group) was analyzed. RNA preparation, hybridization, staining, and scanning of the GeneChip MOE 430A 2.0 was carried out by the Progenika Biopharma laboratories.
RESULTS
Tau expression in wt and tau
−/− mice Firstly, tau +/+ and tau −/− (n = 6 for each genotype) isolated from the same offspring were used for our analysis (Fig. 1A) . Western blot analysis showed the amount of tau protein in wt and tau −/− mice using as control two antibodies raised against the C-terminal part of tau (BR-133) and against phosphotau (PHF-1). An antibody that recognizes β-actin was used as control for protein loading (Fig. 1B) . We further performed immunohistochemistry analysis using a monoclonal antibody (Tau-1) to detect tau protein in mice from both groups. In agreement with previous results, immunoreactivity level of the tau protein observed in wt brains was absent in tau −/− animals (Fig. 1C) . Gene expression was also analyzed (see Methods) and the only transcript that showed a drastic decrease in tau 
Effect of tau on waking behavior
Behavioral wakefulness (AWK and QWK) was markedly different between genotypes (Table 1) . Thus, tau −/− mice showed a significant increased frequency of AWK and QWK episodes in both light and dark periods accompanied by longer duration of QWK in light 1.1 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 0.9 ± 0.1 1.1 ± 0.1 1 ± 0.1 Number REM episodes/hour 3.4 ± 0.5 3.5 ± 0.5 3.2 ± 0.3 3.5 ± 0.3 3.3 ± 0.4 3.5 ± 0.4
Results are expressed as mean ± SEM (n = 6 per genotype) during the 12 h. light period, 12 h. dark period, and nycthemeral cycle (24 h). * P < 0.05, * * P < 0.005, Mann-Whitney ANOVA.
( Fig. 2 , right superior panel) and AWK in dark hours (Table 1 ). An exception occurred with the duration of AWK in light and QWK in dark periods, which showed comparable results in both mouse strains. Hourly duration of QWK significantly increased in tau-deficient animals during most of the light hours confirming that the longer duration of QWK in tau −/− mice is mainly a diurnal phenomenon (Fig. 2, left superior panel) . Tau −/− mice also showed a significantly higher number of transitions between AWK and QWK (and vice versa) in light (p < 0.05) and dark (p < 0.003) periods (data not shown).
The absence of tau was significantly associated to longer AWK in dark periods (29% on average), and increased number of AWK periods in both dark (58% on average) and light (40% on average) phases. Tau −/− mice also showed significantly longer periods of QWK in light periods (70% on average), and a higher number of QWK periods in light (49% on average) and dark (31% on average) phases.
Effects of tau on sleep-wake organization
Both groups of mice exhibited a diurnal preference for sleep (wt: p < 0.01; tau −/− : p < 0.01). Taudeficient mice showed a significant decrement of sleep in both light and dark periods (p < 0.004), which was consequently balanced with longer wakefulness time in both periods (p < 0.004).
Tau −/− mice spent significantly less time in NREM sleep during light (−25%; p < 0.004) and dark (−26%; p < 0.004) periods (Table 1) , which was mainly due to a decreased duration of NREM1 in both periods (p < 0.004) (Fig. 2, right middle panel) . This shortening of NREM1 occurred in most of the light and dark hours (Fig. 2, left middle panel) . Mean duration of NREM1 episodes was also significantly shorter in tau-deficient animals in both light and dark phases (p < 0.003). Further analysis revealed that the number of transitions between NREM sleep (mainly NREM1) and wakefulness was abnormally increased in tau −/− mice during the light phase (+70%; p < 0.006) (Fig. 3) . Wakefulness to NREM sleep transitions were also significantly facilitated in this genotype during light periods (+54%; p < 0.04) (Fig. 3) . Although similar trends were observed in dark phases, they did not reach statistical significance (Fig. 3) . NREM2 (deep sleep) and REM sleep parameters did not differ between the two genotypes ( Table 1 , Fig. 2 ), suggesting that tau protein does not interfere with the control and maintenance of these cerebral states.
To further investigate the role of tau protein in the temporal organization of wakefulness and sleep, the wake and sleep time distribution was determined in light and dark periods as a function of bout duration (Fig. 4) . Compared with wt, tau −/− mice showed a significantly higher density of WK bouts with durations ranged between 11 and 80 s (p < 0.05) during the light period. This result was extended to the dark period for the shortest wake bouts (p < 0.03). In contrast, the lack of neuronal tau decreased the amount of wake bouts with durations ranged from 21 to 160 s (p < 0.05) selectively in dark periods. Density of wake bouts longer than 161 s was unaffected in tau-deficient animals in both light and dark periods (Fig. 4A) . Sleep fragments were significantly shorter (ranged from 10 to 40 s) in tau −/− animals when compared with wt in light periods (p < 0.008); the same trend was present in dark periods although they did not reach statistical significance (except for the 10 s duration). Longer sleep bouts (ranged from 81 to 640 s) were more prominent in wt mice during light and dark phases when compared with tau −/− mice (p < 0.05) (Fig. 4B ) denoting an impaired sleep continuity associated with the lack of tau protein.
Effects of tau on sleep-wake neurophysiology
LFP power spectra were obtained for each mouse, and normalized spectral contributions were compared between genotypes for each cerebral state (Fig. 5) . Taudeficient animals exhibited a significant decrement of delta power during wakefulness in both light (0.5-4 Hz; p < 0.05) and dark (1.5-2.5 Hz; p < 0.05) periods. More noticeably, the lack of tau was also associated with an increased power density in frequencies ranged from 9.5 to 16.5 Hz (p < 0.04) during wakefulness in the light period. Delta power (3 Hz; p < 0.04) also showed a significant decline in NREM sleep followed by an enhanced synchronization around sleep spindle frequency range (11.5 Hz; p < 0.02) in tau −/− mice 
DISCUSSION
Here we show major sleep-wake abnormalities in tau-deficient animals including increased wakefulness and decreased NREM sleep time, a higher number of state transitions between NREM and wake, and shortened sleep bouts. Altered sleep structure was accompanied by changes in the underlying neurophysiology of wakefulness and NREM sleep. These results suggest, for the first time, an indirect involvement of tau in the circadian regulation of the sleep-wake cycle modulating not only the control and maintenance of global brain states but also the LFP oscillatory patterns underlying sleep-wake states.
Previous studies have reported that tau-deficient mice show hyperactivity during spontaneous locomotor behavior [5] , which might lead to sleep alterations found in the present study. Despite motor behavior was differently assessed in the work performed by Ikegami and colleagues [5] and ours (they measured spontaneous activity and speed of movement during 30-m using an open-field test, whereas the animal was engaged in exploratory behavior like locomotion, whisking, and sniffing in our AWK condition), our study confirmed that tau-deficient mice show a certain pattern of hyperactivity (see Table 1 ). Regardless of this, the causal role of hyperactivity on sleep alterations reported in tau −/− mice remains uncertain since these animals also showed significantly longer periods of QWK in light and dark phases.
Sleep is regulated by homeostatic mechanisms that control the intensity and amount of sleep as a function of prior sleep-wake history. The duration of prior wakefulness is the main factor influencing subsequent sleep duration and its intensity [17] . Traditional markers of sleep homeostasis include longer duration of NREM sleep and increased slow-wave activity. Both factors have been linked to changes in synaptic strength in local neuronal networks [18] and hypothesized to be integrated even at the level of individual cortical neurons [19] . In our study, tau-deficient mice exhibited an increased amount of wakefulness (see Ta- ble 1) not followed by variations in the sleep homeostasis markers mentioned above. Instead, tau −/− mice showed significant shortening of NREM time and diminished delta power during this cerebral state. Two complementary hypotheses could account for these results. Slow wave activity (< 4 Hz) results from membrane hyperpolarization associated with slow oscillations in membrane potential of cortical and thalamocortical neurons [20, 21] . Tau can establish interactions with the neural membrane through its amino-terminal projection domain [22, 23] , suggesting a role of tau at stabilizing microtubules close to membranes. The lack of tau could not drastically affect the morphology of nerve cells [6] , but does produce subtle modifications of intrinsic membrane properties affecting in turn the emergence of slow-wave activity during NREM sleep. Secondly, the presence of a higher number of NREM episodes in tau −/− mice contrasts with the shorter duration of these episodes (see Table 1 ). This result suggests an unexpected contribution of tau protein on the formation of neural circuits controlling NREM sleep regulation and maintenance. Both hypotheses need further investigation to confirm the mechanistic role of tau in sleep phenomena.
Tau-deficient animals exhibited an increased number of shorter bouts of wake during light periods (ranged from 10 to 80-s, see Fig. 4 ) which contributed to sleep fragmentation in this mouse strain. A higher density of shorter sleep bouts and a lower amount of longer sleep bouts during light periods definitively confirmed impaired sleep continuity in tau −/− mice. Hypothetically, the lack of tau might be affecting the circadian timing of wakefulness in light and dark periods which in turn would impact the sleep continuity. Given the absence of interactions between tau and the neuronal membrane in the tau −/− mice [22] , anomalous circadian regulation of ion channels might partially account for these results. Thus, T-type voltage-gated calcium channels have demonstrated variations associated with sleep-wake cycles in rodents, and each subtype of Ttype voltage-gated calcium channels results in specific circadian behavior depending on the day period [24] . More specifically, in the suprachiasmatic nuclei, the master circadian pacemaker in mammals, gene expression of these specific ion channels is greatest during the transition period from light to dark (when the animal is typically asleep), whereas gene expression in the cerebellum peaks in the middle of the dark period (when the animal is most active) [25] .
Subtle disruptions in neuronal microtubule dynamics in response to the absence of tau may have important consequences on circadian activity patterns. Indeed, microtubules have demonstrated modulation of the sensitivity states of different melatonine receptors [12, 13] , which may impact on the regulation of the sleep-wake cycle. Patients of Alzheimer's disease (AD), a neurodegenerative disorder characterized by microtubule derangement [26] [27] [28] , typically experience sleep disturbances [29] [30] [31] [32] likely due to alterations in the circadian timing system (for a review, see [33] ). Impaired functioning of melatonin receptors triggered by abnormal microtubule dynamics could underlie sleep disturbances in AD patients. Our results, although related to lack of tau rather than to its abnormal hyperphosphorylation, indirectly support the above findings, suggesting that tau, through its role in microtubule assembly, might contribute to the integrity of melatonin-regulated physiological processes affecting the sleep-wake circadian rhythm. In this way, it has been described that melatonin receptor (MT2) binds to delta catenin [34] , delta catenin binds to cofilin [35] , and cofilin binds tau [36] . Moreover, delta catenin has also been shown to directly interact with presenilin-1 [37] and presenilin-1 binds tau protein [38] .
In conclusion, evidence suggests that tau protein indirectly participates in the regulation of the sleep-wake cycle modulating not only the control and maintenance of global brain states but also the LFP oscillatory patterns underlying sleep-wake states. Therefore, these results support the role of microtubule dynamics on sleepwake regulation and provide insights into a better understanding of the molecular basis of cellular disease processes.
